A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Studyto Evaluate the Safety and Efficacy of Benrali21Jmab 30 mg sc in Patients with Sewre Asthma Uncontrolled on Standard of care Treatment

    Project: Other project

    Project Details

    StatusFinished
    Effective start/end date10/12/1710/11/19

    Funding

    • AstraZeneca LP: $23,831.53